Teladoc Health, Inc. provides business-to-business virtual health care services in the United States and internationally. The company is headquartered in Purchase, New York.
| Revenue (TTM) | $2.51B |
| Gross Profit (TTM) | $1.74B |
| EBITDA | $47.51M |
| Operating Margin | -7.94% |
| Return on Equity | -12.40% |
| Return on Assets | -3.14% |
| Revenue/Share (TTM) | $14.17 |
| Book Value | $7.41 |
| Price-to-Book | 1.24 |
| Price-to-Sales (TTM) | 0.65 |
| EV/Revenue | 0.775 |
| EV/EBITDA | 9.08 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -2.50% |
| Shares Outstanding | $180.51M |
| Float | $179.34M |
| % Insiders | 0.69% |
| % Institutions | 83.63% |
Volatility is currently contracting
Hims & Hers Health continues to drive impressive growth through its subscription-based consumer wellness platform. Teladoc Health maintains a dominant market share with over 100 million global members and significant institutional partnerships.
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
Teladoc's business is slowly improving due to several initiatives. However, the company still faces potential headwinds that could derail its progress.
The latest trading day saw Teladoc (TDOC) settling at $8.48, representing a -2.42% change from its previous close.
Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Veteran enterprise sales executive brings decades of experience scaling companies and leading successful commercial organizations SURPRISE, Ariz., June 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control solutions for managing rodent populations, today announced the appointment of Jack Karabees as Executive Vice President of Sales.
Teladoc (TDOC) concluded the recent trading session at $7.81, signifying a +1.56% move from its prior day's close.
Teladoc (TDOC) reached $7.57 at the closing of the latest trading day, reflecting a +1.47% change compared to its last close.
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights. We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
TDOC gains on Integrated Care growth, international expansion and cost cuts, but BetterHelp weakness and ongoing losses remain key challenges.
